Celgene's VIDAZA Receives Positive CHMP Opinion as New Treatment for Elderly Patients with Acute Myeloid Leukaemia
September 25, 2015 at 04:23 AM EDT
Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (NASDAQ: CELG) today announced that that ...